Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The lead product candidate, GRANITE, is a personalized neoantigen-based immunotherapy. The second product candidate, SLATE, is a shared neoantigen (âoff-the-shelfâ) immunotherapy. The company has developed its product candidates using two key pillarsâa proprietary machine learning-based platform, Gritstone EDGEâ˘, which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patientâs tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patientsâ TSNA to drive the patientâs immune system to attack and destroy tumors. Source
No articles found.
Lipocine Inc. is a clinical-stage biopharmaceutical company focused on metabolic a...
Lipocine Inc. is a clinical-stage biopharmaceut...
Compugen is a drug discovery company with a unique, broadly applicable, predictive...
Compugen is a drug discovery company with a uni...
NanoString Technologies is a leading provider of life science tools for translatio...
NanoString Technologies is a leading provider o...
NuvectraÂŽ is a neurostimulation company committed to helping physicians improve t...
NuvectraÂŽ is a neurostimulation company commit...
WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...
WuXi Biologics (stock code: 2269.HK), a Hong Ko...
Biocept, Inc. is a molecular diagnostics company with commercialized assays for lu...
Biocept, Inc. is a molecular diagnostics compan...
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...
Incyte Corporation is a Wilmington, Delaware-ba...
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, d...
Rigel Pharmaceuticals, Inc. is a biotechnology ...
IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunot...
IMV Inc. is a clinical stage biopharmaceutical ...
TCR² is an innovative immunotherapy company developing the next generation of T c...
TCR² is an innovative immunotherapy company de...
Join the National Investor Network and get the latest information with your interests in mind.